Danger-associated molecular patterns (DAMPs) in acute lung injury

Journal of Pathology

Volumn 229, Issue 2, 2013, Pages 145-156

  Tolle, Leslie B ^a   Standiford, Theodore J ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

acute lung injury; acute respiratory distress syndrome; chemokines; fibrosis; pathogen recognition receptors

Indexed keywords

BETA DEFENSIN; FIBRONECTIN; HEAT SHOCK PROTEIN; HEPARAN SULFATE; HIGH MOBILITY GROUP B1 PROTEIN; HYALURONIC ACID; MICRORNA; NOD LIKE RECEPTOR 3; NUCLEIC ACID; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; PATTERN RECOGNITION RECEPTOR; SURFACTANT PROTEIN A; SURFACTANT PROTEIN D; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR AGONIST; UNCLASSIFIED DRUG; URIC ACID;

ACUTE LUNG INJURY; ADULT RESPIRATORY DISTRESS SYNDROME; EXTRACELLULAR MATRIX; HUMAN; INTERSTITIUM; MOLECULE; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ACUTE LUNG INJURY; ANIMALS; EXTRACELLULAR MATRIX; HUMANS; LIGANDS; LUNG; PULMONARY SURFACTANT-ASSOCIATED PROTEINS; RECEPTORS, IMMUNOLOGIC; SIGNAL TRANSDUCTION; STRESS, PHYSIOLOGICAL; TOLL-LIKE RECEPTORS;

EID: 84871070851     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.4124     Document Type: Review

References (133)

1. Bastarache JA, Ware LB, Bernard GR,. The role of the coagulation cascade in the continuum of sepsis and acute lung injury and acute respiratory distress syndrome. Semin Respir Crit Care Med 2006; 27: 365-376. (Pubitemid 44272605)
2. Hallgren R, Gerdin B, Tengblad A, et al,. Accumulation of hyaluronan (hyaluronic acid) in myocardial interstitial tissue parallels development of transplantation edema in heart allografts in rats. J Clin Invest 1990; 85: 668-673. (Pubitemid 20087467)
3. Tomashefski JF Jr,. Pulmonary pathology of acute respiratory distress syndrome. Clin Chest Med 2000; 21: 435-466.
4. Martin C, Papazian L, Payan MJ, et al,. Pulmonary fibrosis correlates with outcome in adult respiratory distress syndrome. A study in mechanically ventilated patients. Chest 1995; 107: 196-200.
5. Jiang D, Liang J, Li Y, et al,. The role of Toll-like receptors in non-infectious lung injury. Cell Res 2006; 16: 693-701. (Pubitemid 44258922)
6. Kovach MA, Standiford TJ,. Toll like receptors in diseases of the lung. Int Immunopharmacol 2011; 11: 1399-1406.
7. Pisetsky D,. Cell death in the pathogenesis of immune-mediated diseases: the role of HMGB1 and DAMP-PAMP complexes. Swiss Med Wkly 2011; 141: w13256.
8. Rubartelli A, Lotze MT,. Inside, outside, upside down: damage-associated molecular-pattern molecules (DAMPs) and redox. Trends Immunol 2007; 28: 429-436. (Pubitemid 47444554)
9. Okamura Y, Watari M, Jerud ES, et al,. The extra domain A of fibronectin activates Toll-like receptor 4. J Biol Chem 2001; 276: 10229-10233.
10. Termeer C, Benedix F, Sleeman J, et al,. Oligosaccharides of hyaluronan activate dendritic cells via toll-like receptor 4. J Exp Med 2002; 195: 99-111. (Pubitemid 34074500)
11. Vabulas RM, Ahmad-Nejad P, da Costa C, et al,. Endocytosed HSP60s use toll-like receptor 2 (TLR2) and TLR4 to activate the toll/interleukin-1 receptor signaling pathway in innate immune cells. J Biol Chem 2001; 276: 31332-31339. (Pubitemid 37385004)
12. Kokkola R, Andersson A, Mullins G, et al,. RAGE is the major receptor for the proinflammatory activity of HMGB1 in rodent macrophages. Scand J Immunol 2005; 61: 1-9. (Pubitemid 40188342)
13. Park JS, Gamboni-Robertson F, He Q, et al,. High mobility group box1 protein interacts with multiple Toll-like receptors. Am J Physiol Cell Physiol 2006; 290: C917-924.
14. Park JS, Svetkauskaite D, He Q, et al,. Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box1 protein. J Biol Chem 2004; 279: 7370-7377. (Pubitemid 38294612)
15. Popovic PJ, DeMarco R, Lotze MT, et al,. High mobility group B1 protein suppresses the human plasmacytoid dendritic cell response to TLR9 agonists. J Immunol 2006; 177: 8701-8707. (Pubitemid 44893835)
16. Henning LN, Azad AK, Parsa KV, et al,. Pulmonary surfactant protein A regulates TLR expression and activity in human macrophages. J Immunol 2008; 180: 7847-7858.
17. Yamamoto M, Sato S, Hemmi H, et al,. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 2003; 301: 640-643. (Pubitemid 36927946)
18. Nace G, Evankovich J, Eid R, et al,. Dendritic cells and damage-associated molecular patterns: endogenous danger signals linking innate and adaptive immunity. J Innate Immun 2012; 4: 6-15.
19. Cargnello M, Roux PP,. Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases. Microbiol Mol Biol Rev 2011; 75: 50-83.
20. Standiford LR, Standiford TJ, Newstead MJ, et al,. TLR4-dependent GM-CSF protects against lung injury in Gram-negative bacterial pneumonia. Am J Physiol Lung Cell Mol Physiol 2012; 302: L447-454.
21. Jiang D, Liang J, Fan J, et al,. Regulation of lung injury and repair by Toll-like receptors and hyaluronan. Nat Med 2005; 11: 1173-1179. (Pubitemid 43093664)
22. Qureshi ST, Zhang X, Aberg E, et al,. Inducible activation of TLR4 confers resistance to hyperoxia-induced pulmonary apoptosis. J Immunol 2006; 176: 4950-4958.
23. Zhang X, Shan P, Qureshi S, et al,. Cutting edge: TLR4 deficiency confers susceptibility to lethal oxidant lung injury. J Immunol 2005; 175: 4834-4838. (Pubitemid 41456364)
24. Murray LA, Knight DA, McAlonan L, et al,. Deleterious role of TLR3 during hyperoxia-induced acute lung injury. Am J Respir Crit Care Med 2008; 178: 1227-1237.
25. Sloane JA, Blitz D, Margolin Z, et al,. A clear and present danger: endogenous ligands of Toll-like receptors. Neuromol Med 2010; 12: 149-163.
26. Peters JH, Grote MN, Lane NE, et al,. Changes in plasma fibronectin isoform levels predict distinct clinical outcomes in critically ill patients. Biomark Insights 2011; 6: 59-68.
27. Grinnell F,. Fibronectin and wound healing. J Cell Biochem 1984; 26: 107-116. (Pubitemid 15180965)
28. Labat-Robert J,. Cell-matrix interactions, the role of fibronectin and integrins. A survey. Pathol Biol (Paris) 2012; 60: 15-19.
29. Gondokaryono SP, Ushio H, Niyonsaba F, et al,. The extra domain A of fibronectin stimulates murine mast cells via toll-like receptor 4. J Leukoc Biol 2007; 82: 657-665. (Pubitemid 47367158)
30. Lefebvre JS, Levesque T, Picard S, et al,. Extra domain A of fibronectin primes leukotriene biosynthesis and stimulates neutrophil migration through activation of Toll-like receptor 4. Arthritis Rheum 2011; 63: 1527-1533.
31. McFadden JP, Basketter DA, Dearman RJ, et al,. Extra domain A-positive fibronectin-positive feedback loops and their association with cutaneous inflammatory disease. Clin Dermatol 2011; 29: 257-265.
32. Durr RA, Dubaybo BA, Thet LA,. Repair of chronic hyperoxic lung injury: changes in lung ultrastructure and matrix. Exp Mol Pathol 1987; 47: 219-240. (Pubitemid 18045267)
33. Kradin RL, Zhu Y, Hales CA, et al,. Response of pulmonary macrophages to hyperoxic pulmonary injury. Acquisition of surface fibronectin and fibrin/ogen and enhanced expression of a fibronectin receptor. Am J Pathol 1986; 125: 349-357. (Pubitemid 17194693)
34. Maniscalco WM, Watkins RH, Chess PR, et al,. Cell-specific expression of fibronectin and EIIIA and EIIIB splice variants after oxygen injury. Am J Physiol 1998; 274: L599-609.
35. Kelley J, Chrin L, Shull S, et al,. Bleomycin selectively elevates mRNA levels for procollagen and fibronectin following acute lung injury. Biochem Biophys Res Commun 1985; 131: 836-843. (Pubitemid 16224967)
36. Lazenby AJ, Crouch EC, McDonald JA, et al,. Remodeling of the lung in bleomycin-induced pulmonary fibrosis in the rat. An immunohistochemical study of laminin, type IV collagen, and fibronectin. Am Rev Respir Dis 1990; 142: 206-214. (Pubitemid 20224604)
37. Bellows CF, Brain JD,. Role of fibronectin in pancreatitis-associated lung injury. Dig Dis Sci 2003; 48: 1445-1452. (Pubitemid 36936676)
38. Pendino KJ, Shuler RL, Laskin JD, et al,. Enhanced production of interleukin-1, tumor necrosis factor-α, and fibronectin by rat lung phagocytes following inhalation of a pulmonary irritant. Am J Respir Cell Mol Biol 1994; 11: 279-286.
39. Peters JH, Ginsberg MH, Case CM, et al,. Release of soluble fibronectin containing an extra type III domain (ED1) during acute pulmonary injury mediated by oxidants or leukocytes in vivo. Am Rev Respir Dis 1988; 138: 167-174.
40. Morales MM, Pires-Neto RC, Inforsato N, et al,. Small airway remodeling in acute respiratory distress syndrome: a study in autopsy lung tissue. Crit Care 2011; 15: R4.
41. Allegra L, Della Patrona S, Petrigni G., Hyaluronic acid: perspectives in lung diseases. Handb Exp Pharmacol 2012; 207: 385-401.
42. Termeer CC, Hennies J, Voith U, et al,. Oligosaccharides of hyaluronan are potent activators of dendritic cells. J Immunol 2000; 165: 1863-1870. (Pubitemid 30643136)
43. Taylor KR, Trowbridge JM, Rudisill JA, et al,. Hyaluronan fragments stimulate endothelial recognition of injury through TLR4. J Biol Chem 2004; 279: 17079-17084. (Pubitemid 38560463)
44. Jiang D, Liang J, Noble PW,. Regulation of non-infectious lung injury, inflammation, and repair by the extracellular matrix glycosaminoglycan hyaluronan. Anat Rec (Hoboken) 2010; 293: 982-985.
45. Hernnas J, Nettelbladt O, Bjermer L, et al,. Alveolar accumulation of fibronectin and hyaluronan precedes bleomycin-induced pulmonary fibrosis in the rat. Eur Respir J 1992; 5: 404-410.
46. Nettelbladt O, Bergh J, Schenholm M, et al,. Accumulation of hyaluronic acid in the alveolar interstitial tissue in bleomycin-induced alveolitis. Am Rev Respir Dis 1989; 139: 759-762. (Pubitemid 19084402)
47. Nettelbladt O, Hallgren R,. Hyaluronan (hyaluronic acid) in bronchoalveolar lavage fluid during the development of bleomycin-induced alveolitis in the rat. Am Rev Respir Dis 1989; 140: 1028-1032. (Pubitemid 19259508)
48. Nettelbladt O, Tengblad A, Hallgren R,. Lung accumulation of hyaluronan parallels pulmonary edema in experimental alveolitis. Am J Physiol 1989; 257: L379-384.
49. Hallgren R, Samuelsson T, Laurent TC, et al,. Accumulation of hyaluronan (hyaluronic acid) in the lung in adult respiratory distress syndrome. Am Rev Respir Dis 1989; 139: 682-687. (Pubitemid 19084390)
50. Whitelock JM, Iozzo RV,. Heparan sulfate: a complex polymer charged with biological activity. Chem Rev 2005; 105: 2745-2764. (Pubitemid 41055329)
51. Johnson GB, Brunn GJ, Kodaira Y, et al,. Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulfate by Toll-like receptor 4. J Immunol 2002; 168: 5233-5239. (Pubitemid 34495991)
52. Johnson GB, Brunn GJ, Platt JL,. Cutting edge: an endogenous pathway to systemic inflammatory response syndrome (SIRS)-like reactions through Toll-like receptor 4. J Immunol 2004; 172: 20-24. (Pubitemid 38020450)
53. Tsan MF, Gao B,. Heat shock protein and innate immunity. Cell Mol Immunol 2004; 1: 274-279.
54. Asea A., Heat shock proteins and toll-like receptors. Handb Exp Pharmacol 2008; 183: 111-127.
55. Ohashi K, Burkart V, Flohe S, et al,. Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex. J Immunol 2000; 164: 558-561. (Pubitemid 30043672)
56. Asea A, Rehli M, Kabingu E, et al,. Novel signal transduction pathway utilized by extracellular HSP70: role of toll-like receptor (TLR) 2 and TLR4. J Biol Chem 2002; 277: 15028-15034. (Pubitemid 34952579)
57. Vabulas RM, Ahmad-Nejad P, Ghose S, et al,. HSP70 as endogenous stimulus of the Toll/interleukin-1 receptor signal pathway. J Biol Chem 2002; 277: 15107-15112. (Pubitemid 34952589)
58. Vabulas RM, Braedel S, Hilf N, et al,. The endoplasmic reticulum-resident heat shock protein Gp96 activates dendritic cells via the Toll-like receptor 2/4 pathway. J Biol Chem 2002; 277: 20847-20853. (Pubitemid 34967392)
59. Wheeler DS, Chase MA, Senft AP, et al,. Extracellular Hsp72, an endogenous DAMP, is released by virally infected airway epithelial cells and activates neutrophils via Toll-like receptor (TLR)-4. Respir Res 2009; 10: 31.
60. Chase MA, Wheeler DS, Lierl KM, et al,. Hsp72 induces inflammation and regulates cytokine production in airway epithelium through a TLR4- and NF-κB-dependent mechanism. J Immunol 2007; 179: 6318-6324.
61. Wheeler DS,. Stress proteins and acute lung injury: dreams can come true... eventually. Crit Care Med 2008; 36: 360-362.
62. Tanaka K, Tanaka Y, Namba T, et al,. Heat shock protein 70 protects against bleomycin-induced pulmonary fibrosis in mice. Biochem Pharmacol 2010; 80: 920-931.
63. Wong HR, Menendez IY, Ryan MA, et al,. Increased expression of heat shock protein-70 protects A549 cells against hyperoxia. Am J Physiol 1998; 275: L836-841.
64. Shao L, Perez RE, Gerthoffer WT, et al,. Heat shock protein 27 protects lung epithelial cells from hyperoxia-induced apoptotic cell death. Pediatr Res 2009; 65: 328-333.
65. Chambellan A, Cruickshank PJ, McKenzie P, et al,. Gene expression profile of human airway epithelium induced by hyperoxia in vivo. Am J Respir Cell Mol Biol 2006; 35: 424-435. (Pubitemid 44477643)
66. Ganter MT, Ware LB, Howard M, et al,. Extracellular heat shock protein 72 is a marker of the stress protein response in acute lung injury. Am J Physiol Lung Cell Mol Physiol 2006; 291: L354-361. (Pubitemid 44343710)
67. Pespeni M, Mackersie RC, Lee H, et al,. Serum levels of Hsp60 correlate with the development of acute lung injury after trauma. J Surg Res 2005; 126: 41-47. (Pubitemid 40726244)
68. Erlandsson Harris H, Andersson U., Mini-review: The nuclear protein HMGB1 as a proinflammatory mediator. Eur J Immunol 2004; 34: 1503-1512. (Pubitemid 39256031)
69. Lotze MT, Deisseroth A, Rubartelli A,. Damage associated molecular pattern molecules. Clin Immunol 2007; 124: 1-4. (Pubitemid 46936248)
70. Scaffidi P, Misteli T, Bianchi ME,. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 2002; 418: 191-195. (Pubitemid 34773774)
71. Hori O, Brett J, Slattery T, et al,. The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system. J Biol Chem 1995; 270: 25752-25761.
72. Huttunen HJ, Fages C, Kuja-Panula J, et al,. Receptor for advanced glycation end products-binding COOH-terminal motif of amphoterin inhibits invasive migration and metastasis. Cancer Res 2002; 62: 4805-4811.
73. Huttunen HJ, Fages C, Rauvala H,. Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-κB require the cytoplasmic domain of the receptor but different downstream signaling pathways. J Biol Chem 1999; 274: 19919-19924.
74. Park JS, Gamboni-Robertson F, He QB, et al,. High mobility group box1 protein interacts with multiple Toll-like receptors. Am J Physiol Cell Physiol 2006; 290: C917-924.
75. Hreggvidsdottir HS, Ostberg T, Wahamaa H, et al,. The alarmin HMGB1 acts in synergy with endogenous and exogenous danger signals to promote inflammation. J Leukoc Biol 2009; 86: 655-662.
76. van Beijnum JR, Buurman WA, Griffioen AW,. Convergence and amplification of toll-like receptor (TLR) and receptor for advanced glycation end products (RAGE) signaling pathways via high mobility group B1 (HMGB1). Angiogenesis 2008; 11: 91-99.
77. Yu M, Wang H, Ding A, et al,. HMGB1 signals through toll-like receptor (TLR)-4 and TLR2. Shock 2006; 26: 174-179. (Pubitemid 44162504)
78. Abraham E, Arcaroli J, Carmody A, et al,. HMG-1 as a mediator of acute lung inflammation. J Immunol 2000; 165: 2950-2954.
79. Ren D, Sun R, Wang S,. Role of inducible nitric oxide synthase expressed by alveolar macrophages in high mobility group box1-induced acute lung injury. Inflamm Res 2006; 55: 207-215. (Pubitemid 44035072)
80. He M, Kubo H, Ishizawa K, et al,. The role of the receptor for advanced glycation end-products in lung fibrosis. Am J Physiol Lung Cell Mol Physiol 2007; 293: L1427-1436. (Pubitemid 350255025)
81. Kim JY, Park JS, Strassheim D, et al,. HMGB1 contributes to the development of acute lung injury after hemorrhage. Am J Physiol Lung Cell Mol Physiol 2005; 288: L958-965. (Pubitemid 40547924)
82. Kong X, Zhang C, Jin X, et al,. The effect of HMGB1 A box on lung injury in mice with acute pancreatitis. Biofactors 2011; 37: 323-327.
83. Fan J, Li Y, Levy RM, et al,. Hemorrhagic shock induces NAD(P)H oxidase activation in neutrophils: role of HMGB1-TLR4 signaling. J Immunol 2007; 178: 6573-6580. (Pubitemid 46717441)
84. Li Y, Xiang M, Yuan Y, et al,. Hemorrhagic shock augments lung endothelial cell activation: role of temporal alterations of TLR4 and TLR2. Am J Physiol Regul Integr Comp Physiol 2009; 297: R1670-1680.
85. Ueno H, Matsuda T, Hashimoto S, et al,. Contributions of high mobility group box protein in experimental and clinical acute lung injury. Am J Respir Crit Care Med 2004; 170: 1310-1316. (Pubitemid 39657195)
86. Alexopoulou L, Holt AC, Medzhitov R, et al,. Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3. Nature 2001; 413: 732-738. (Pubitemid 33009951)
87. Diebold SS, Kaisho T, Hemmi H, et al,. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 2004; 303: 1529-1531. (Pubitemid 38314425)
88. Hemmi H, Takeuchi O, Kawai T, et al,. A Toll-like receptor recognizes bacterial DNA. Nature 2000; 408: 740-745. (Pubitemid 32015992)
89. Platz J, Beisswenger C, Dalpke A, et al,. Microbial DNA induces a host defense reaction of human respiratory epithelial cells. J Immunol 2004; 173: 1219-1223. (Pubitemid 38924299)
90. Urbonaviciute V, Furnrohr BG, Meister S, et al,. Induction of inflammatory and immune responses by HMGB1-nucleosome complexes: implications for the pathogenesis of SLE. J Exp Med 2008; 205: 3007-3018.
91. Barrat FJ, Meeker T, Gregorio J, et al,. Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus. J Exp Med 2005; 202: 1131-1139. (Pubitemid 41464506)
92. Kariko K, Ni H, Capodici J, et al,. mRNA is an endogenous ligand for Toll-like receptor 3. J Biol Chem 2004; 279: 12542-12550. (Pubitemid 38445825)
93. Cavassani KA, Ishii M, Wen H, et al,. TLR3 is an endogenous sensor of tissue necrosis during acute inflammatory events. J Exp Med 2008; 205: 2609-2621.
94. Boule MW, Broughton C, Mackay F, et al,. Toll-like receptor 9-dependent and -independent dendritic cell activation by chromatin-immunoglobulin G complexes. J Exp Med 2004; 199: 1631-1640. (Pubitemid 38821996)
95. Tian J, Avalos AM, Mao SY, et al,. Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat Immunol 2007; 8: 487-496. (Pubitemid 46605917)
96. Ivanov S, Dragoi AM, Wang X, et al,. A novel role for HMGB1 in TLR9-mediated inflammatory responses to CpG-DNA. Blood 2007; 110: 1970-1981. (Pubitemid 47443911)
97. Cai ZG, Zhang SM, Zhang Y, et al,. MicroRNAs are dynamically regulated and play an important role in LPS-induced lung injury. Can J Physiol Pharmacol 2012; 90: 37-43.
98. Zhou T, Garcia JG, Zhang W,. Integrating microRNAs into a system biology approach to acute lung injury. Transl Res 2011; 157: 180-190.
99. O'Neill LA, Sheedy FJ, McCoy CE,. MicroRNAs: the fine-tuners of Toll-like receptor signalling. Nat Rev Immunol 2011; 11: 163-175.
100. Quinn SR, O'Neill LA,. A trio of microRNAs that control Toll-like receptor signalling. Int Immunol 2011; 23: 421-425.
101. Fabbri M, Paone A, Calore F, et al,. MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response. Proc Natl Acad Sci USA 2012; 109: E2110-6. Epub ahead of print.
102. Lehrer RI, Lichtenstein AK, Ganz T,. Defensins: antimicrobial and cytotoxic peptides of mammalian cells. Annu Rev Immunol 1993; 11: 105-128. (Pubitemid 23115003)
103. Biragyn A, Ruffini PA, Leifer CA, et al,. Toll-like receptor 4-dependent activation of dendritic cells by β-defensin 2. Science 2002; 298: 1025-1029. (Pubitemid 35247310)
104. Biragyn A, Coscia M, Nagashima K, et al,. Murine β-defensin 2 promotes TLR-4/MyD88-mediated and NF-κB-dependent atypical death of APCs via activation of TNFR2. J Leukoc Biol 2008; 83: 998-1008. (Pubitemid 351959881)
105. Funderburg N, Lederman MM, Feng Z, et al,. Human defensin-3 activates professional antigen-presenting cells via Toll-like receptors 1 and 2. Proc Natl Acad Sci USA 2007; 104: 18631-18635. (Pubitemid 350210748)
106. Shu Q, Shi Z, Zhao Z, et al,. Protection against Pseudomonas aeruginosa pneumonia and sepsis-induced lung injury by overexpression of β-defensin-2 in rats. Shock 2006; 26: 365-371. (Pubitemid 44402021)
107. Liu KX, Chen SQ, Zhang H, et al,. Intestinal ischaemia/reperfusion upregulates β-defensin-2 expression and causes acute lung injury in the rat. Injury 2009; 40: 950-955.
108. Kuroki Y, Takahashi M, Nishitani C,. Pulmonary collectins in innate immunity of the lung. Cell Microbiol 2007; 9: 1871-1879. (Pubitemid 47087079)
109. Koptides M, Umstead TM, Floros J, et al,. Surfactant protein A activates NF-κB in the THP-1 monocytic cell line. Am J Physiol 1997; 273: L382-388.
110. Guillot L, Balloy V, McCormack FX, et al,. Cutting edge: the immunostimulatory activity of the lung surfactant protein-A involves Toll-like receptor 4. J Immunol 2002; 168: 5989-5992. (Pubitemid 34620010)
111. Murakami S, Iwaki D, Mitsuzawa H, et al,. Surfactant protein A inhibits peptidoglycan-induced tumor necrosis factor-α secretion in U937 cells and alveolar macrophages by direct interaction with toll-like receptor 2. J Biol Chem 2002; 277: 6830-6837. (Pubitemid 34953065)
112. Yamada C, Sano H, Shimizu T, et al,. Surfactant protein A directly interacts with TLR4 and MD-2 and regulates inflammatory cellular response. Importance of supratrimeric oligomerization. J Biol Chem 2006; 281: 21771-21780. (Pubitemid 44181881)
113. Wu Y, Adam S, Hamann L, et al,. Accumulation of inhibitory κB-α as a mechanism contributing to the anti-inflammatory effects of surfactant protein-A. Am J Respir Cell Mol Biol 2004; 31: 587-594. (Pubitemid 39587487)
114. Sano H, Kuronuma K, Kudo K, et al,. Regulation of inflammation and bacterial clearance by lung collectins. Respirology 2006; 11 (suppl): S46-50.
115. White MK, Baireddy V, Strayer DS,. Natural protection from apoptosis by surfactant protein A in type II pneumocytes. Exp Cell Res 2001; 263: 183-192. (Pubitemid 32989092)
116. Goto H, Ledford JG, Mukherjee S, et al,. The role of surfactant protein A in bleomycin-induced acute lung injury. Am J Respir Crit Care Med 2010; 181: 1336-1344.
117. Cheng IW, Ware LB, Greene KE, et al,. Prognostic value of surfactant proteins A and D in patients with acute lung injury. Crit Care Med 2003; 31: 20-27. (Pubitemid 36151144)
118. Doyle IR, Nicholas TE, Bersten AD,. Serum surfactant protein-A levels in patients with acute cardiogenic pulmonary edema and adult respiratory distress syndrome. Am J Respir Crit Care Med 1995; 152: 307-317.
119. Eisner MD, Parsons P, Matthay MA, et al,. Plasma surfactant protein levels and clinical outcomes in patients with acute lung injury. Thorax 2003; 58: 983-988. (Pubitemid 37392811)
120. Ohya M, Nishitani C, Sano H, et al,. Human pulmonary surfactant protein D binds the extracellular domains of Toll-like receptors 2 and 4 through the carbohydrate recognition domain by a mechanism different from its binding to phosphatidylinositol and lipopolysaccharide. Biochemistry 2006; 45: 8657-8664. (Pubitemid 44078886)
121. Yamazoe M, Nishitani C, Takahashi M, et al,. Pulmonary surfactant protein D inhibits lipopolysaccharide (LPS)-induced inflammatory cell responses by altering LPS binding to its receptors. J Biol Chem 2008; 283: 35878-35888.
122. Ikegami M, Scoville EA, Grant S, et al,. Surfactant protein-D and surfactant inhibit endotoxin-induced pulmonary inflammation. Chest 2007; 132: 1447-1454. (Pubitemid 350155998)
123. King BA, Kingma PS,. Surfactant protein D deficiency increases lung injury during endotoxemia. Am J Respir Cell Mol Biol 2011; 44: 709-715.
124. Fujita M, Shannon JM, Ouchi H, et al,. Serum surfactant protein D is increased in acute and chronic inflammation in mice. Cytokine 2005; 31: 25-33. (Pubitemid 40828355)
125. Casey J, Kaplan J, Atochina-Vasserman EN, et al,. Alveolar surfactant protein D content modulates bleomycin-induced lung injury. Am J Respir Crit Care Med 2005; 172: 869-877. (Pubitemid 41369071)
126. Kersse K, Bertrand MJ, Lamkanfi M, et al,. NOD-like receptors and the innate immune system: coping with danger, damage and death. Cytokine Growth Factor Rev 2011; 22: 257-276.
127. Franchi L, Amer A, Body-Malapel M, et al,. Cytosolic flagellin requires Ipaf for activation of caspase-1 and interleukin 1β in Salmonella-infected macrophages. Nat Immunol 2006; 7: 576-582. (Pubitemid 43797338)
128. Girardin SE, Boneca IG, Viala J, et al,. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J Biol Chem 2003; 278: 8869-8872. (Pubitemid 36800360)
129. Dostert C, Petrilli V, Van Bruggen R, et al,. Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 2008; 320: 674-677. (Pubitemid 351928351)
130. Shi Y, Evans JE, Rock KL,. Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 2003; 425: 516-521. (Pubitemid 37237047)
131. Martinon F, Petrilli V, Mayor A, et al,. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 2006; 440: 237-241. (Pubitemid 43372104)
132. Gasse P, Riteau N, Charron S, et al,. Uric acid is a danger signal activating NALP3 inflammasome in lung injury inflammation and fibrosis. Am J Respir Crit Care Med 2009; 179: 903-913.
133. Yamasaki K, Muto J, Taylor KR, et al,. NLRP3/cryopyrin is necessary for interleukin-1β (IL-1β) release in response to hyaluronan, an endogenous trigger of inflammation in response to injury. J Biol Chem 2009; 284: 12762-12771.